Literature DB >> 11243826

Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin.

F Chiti1, P Mangione, A Andreola, S Giorgetti, M Stefani, C M Dobson, V Bellotti, N Taddei.   

Abstract

beta 2-Microglobulin is a small, major histocompatibility complex class I-associated protein that undergoes aggregation and accumulates as amyloid deposits in human tissues as a consequence of long-term haemodialysis. The folding process of this amyloidogenic protein has been studied in vitro by diluting the guanidine hydrochloride-denatured protein in refolding buffer at pH 7.4 and monitoring the folding process by means of a number of spectroscopic probes that allow the native structure of the protein to be detected as it develops. These techniques include fluorescence spectroscopy, far and near-UV circular dichroism, 8-anilino-1-naphthalenesulfonic acid binding and double jump assays. All spectroscopic probes indicate that a significant amount of structure forms within the dead-time of stopped-flow measurements (<5 ms). The folding reaction goes to completion through a fast phase followed by a slow phase, whose rate constants are ca 5.1 and 0.0030 s(-1) in water, respectively. Unfolding-folding double jump experiments, together with the use of peptidyl prolyl isomerase, reveal that the slow phase of folding of beta 2-microglobulin is not fundamentally determined by cis/trans isomerisation of X-Pro peptide bonds. Other folding-unfolding double jump experiments also suggest that the fast and slow phases of folding are not related to independent folding of different populations of protein molecules. Rather, we provide evidence for a sequential mechanism of folding where denatured beta 2-microglobulin collapses to an ensemble of partially folded conformations (I(1)) which fold subsequently to a more highly structured species (I(2)) and, finally, attain the native state. The partially folded species I(2) appears to be closely similar to previously studied amyloidogenic forms of beta 2-microglobulin, such as those adopted by the protein at mildly acid pH values and by a variant with six residues deleted at the N terminus. Since amyloid formation in vivo originates from partial denaturation of beta 2-microglobulin under conditions favouring the folding process, the long-lived, partially structured species detected here might be significantly populated under some physiological conditions and hence might play an important role in the process of amyloid formation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243826     DOI: 10.1006/jmbi.2000.4478

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  34 in total

1.  The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition.

Authors:  Giuliana Verdone; Alessandra Corazza; Paolo Viglino; Fabio Pettirossi; Sofia Giorgetti; Palma Mangione; Alessia Andreola; Monica Stoppini; Vittorio Bellotti; Gennaro Esposito
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

3.  Topological investigation of amyloid fibrils obtained from beta2-microglobulin.

Authors:  Maria Monti; Serena Principe; Sofia Giorgetti; Palma Mangione; Gianpaolo Merlini; Anne Clark; Vittorio Bellotti; Angela Amoresano; Piero Pucci
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

4.  DE-loop mutations affect beta2 microglobulin stability, oligomerization, and the low-pH unfolded form.

Authors:  Carlo Santambrogio; Stefano Ricagno; Matteo Colombo; Alberto Barbiroli; Francesco Bonomi; Vittorio Bellotti; Martino Bolognesi; Rita Grandori
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

5.  A novel system for continuous protein refolding and on-line capture by expanded bed adsorption.

Authors:  Henrik Ferré; Emmanuel Ruffet; Lise-Lotte B Nielsen; Mogens Holst Nissen; Timothy J Hobley; Owen R T Thomas; Søren Buus
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

Review 6.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

Review 7.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

8.  NMR-based characterization of a refolding intermediate of beta2-microglobulin labeled using a wheat germ cell-free system.

Authors:  Atsushi Kameda; Eugene-Hayato Morita; Kazumasa Sakurai; Hironobu Naiki; Yuji Goto
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

9.  Delineating the conformational elements responsible for Cu(2+)-induced oligomerization of beta-2 microglobulin.

Authors:  Dorottya V Blaho; Andrew D Miranker
Journal:  Biochemistry       Date:  2009-07-21       Impact factor: 3.162

10.  An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril.

Authors:  Magdalena I Ivanova; Michael R Sawaya; Mari Gingery; Antoine Attinger; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.